The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation
- DOI
- 10.1186/s40164-025-00700-0
- Published
- 2025-08-22
- Container
- Experimental Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40164-025-00700-0,
title = {The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation},
author = {Bianca Stiller and Alessia Stefanelli and Hemma Schueffl and Marlene Mathuber and Nadiya Skorokhyd and Judith Gufler and Christine Pirker and Martin Holcmann and Rostyslav Panchuk and Maria Sibilia and Doris Marko and Walter Berger and Christian R. Kowol and Sonja Hager and Petra Heffeter},
year = {2025},
journal = {Experimental Hematology \& Oncology},
doi = {10.1186/s40164-025-00700-0},
url = {https://doi.org/10.1186/s40164-025-00700-0}
}RIS
TY - JOUR TI - The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation AU - Bianca Stiller AU - Alessia Stefanelli AU - Hemma Schueffl AU - Marlene Mathuber AU - Nadiya Skorokhyd AU - Judith Gufler AU - Christine Pirker AU - Martin Holcmann AU - Rostyslav Panchuk AU - Maria Sibilia AU - Doris Marko AU - Walter Berger AU - Christian R. Kowol AU - Sonja Hager AU - Petra Heffeter PY - 2025 JO - Experimental Hematology & Oncology DO - 10.1186/s40164-025-00700-0 UR - https://doi.org/10.1186/s40164-025-00700-0 ER -
APA
Stiller, B., Stefanelli, A., Schueffl, H., Mathuber, M., Skorokhyd, N., Gufler, J., Pirker, C., Holcmann, M., Panchuk, R., Sibilia, M., Marko, D., Berger, W., Kowol, C. R., Hager, S., & Heffeter, P. (2025). The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-025-00700-0
Source records
- crossref · retrieved 2026-09-26T22:49:00.169Z